
Bismuth quadruple regimens improved resistant H. pylori eradication in one trial
AI-summarized from the linked source. Educational brief, not medical advice.
Brief summary
In a Korean multicenter randomized trial of clarithromycin-resistant H. pylori, two 14-day bismuth-containing quadruple regimens achieved higher eradication rates than metronidazole-based triple therapy, with less nausea and vomiting in the amoxicillin-containing bismuth group than the tetracycline-containing group.
What NurseJet pulled from the source
Intention-to-treat eradication was 68.2% with proton-pump inhibitor, amoxicillin, and metronidazole; 84.8% after adding bismuth; and 81.8% with proton-pump inhibitor, bismuth, metronidazole, and tetracycline. Nausea and vomiting occurred in 6.8% versus 25.0% of the two bismuth groups.
Why this matters for nurses
The trial compared complex 14-day multidrug schedules with different eradication and adverse-effect results. Nurses can reinforce the exact prescribed regimen and assess tolerance and adherence barriers.
Bedside takeaway
Use teach-back to support completion of the exact prescribed multidrug H. pylori regimen.
Key takeaways
- Adding bismuth to amoxicillin-metronidazole triple therapy produced a significantly higher intention-to-treat eradication rate than triple therapy alone.
- The two bismuth-containing regimens had comparable eradication rates in intention-to-treat and per-protocol analyses.
- Severe adverse events were rare in the trial, and reported symptoms resolved after treatment discontinuation.
Practice implications
- Use teach-back for each medication and the full 14-day schedule, review ordered precautions and expected adverse effects, and escalate severe or persistent symptoms through the local protocol. Do not substitute antibiotics or bismuth products outside the prescriber's regimen.
Limitations & cautions
- Abstract-only summary. The study was conducted in two regions of the Republic of Korea, the abstract does not report the randomized sample size, and the trial was registered retrospectively; larger studies are needed before broad generalization.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations
Exact source links
Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.
Gut and liver (PubMed)
Gut and liver (PubMed). Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial.
https://pubmed.ncbi.nlm.nih.gov/42740438/
Professional education only


